about
Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response.Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance.Baseline susceptibility of primary HIV-2 to entry inhibitors.miRNA profiling of human naive CD4 T cells links miR-34c-5p to cell activation and HIV replication.The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands.HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique.
P50
Q30370063-8C2FCBF6-5BB9-48C2-A4E9-EB399E22EDCAQ33591409-2A652742-9850-4ED3-91BA-2987EF02DF12Q34290973-5ABF14F1-1892-4AAF-9785-77EDB9343DBBQ37247746-1136C1A2-3F9B-4CAC-9D8A-1888772AAAE8Q38915512-50A35A44-CD2A-47F7-87BC-51600A2582CFQ40403733-C91489B7-48ED-4B38-813D-B1D370E4F9C0Q43143940-BFACAF4A-C72A-486E-8E78-49BD088244C8Q46638450-4CB1BFD4-6346-41FA-B0C3-D15CB87BB337Q46986567-8C005552-D384-4824-AD84-863B79A31DD6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cheila Rocha
@ast
Cheila Rocha
@en
Cheila Rocha
@es
Cheila Rocha
@nl
type
label
Cheila Rocha
@ast
Cheila Rocha
@en
Cheila Rocha
@es
Cheila Rocha
@nl
prefLabel
Cheila Rocha
@ast
Cheila Rocha
@en
Cheila Rocha
@es
Cheila Rocha
@nl
P108
P106
P108
P1153
25226013300
P31
P496
0000-0002-0148-9405